Predictive Effectiveness of the Glasgow Prognostic Score for Gastrointestinal Stromal Tumors

References

• Laurini JA, Carter JE. Gastrointestinal stromal tumors: a review of the literature. Arch Pathol Lab Med. 2010;134(1):134–141. doi:10.1043/2008-0083-RSR2.1
   PubMed Web of Science ®Google Scholar
• Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279(5350):577–580. doi:10.1126/science.279.5350.577
   PubMed Web of Science ®Google Scholar
• Kindblom LR, Aldenborg F, Meis-Kindblom JM. Gastrointestinal pace-maker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am J Pathol. 1998;152:1259–1269.
   PubMed Web of Science ®Google Scholar
• Di Matteo G, Pescarmona E, Peparini N, Di Matteo FM, Zeri KP, Mascagni D, Mele R, Maturo A, Redler A, De Antoni E. Histopathological features and clinical course of the gastrointestinal stromal tumors. Hepatogastroenterology 2002;49:1013–1016.
   PubMedGoogle Scholar
• Tornoczky T, Kalman E, Hegedus G, Horvath OP, Sapi Z, et al. High mitotic index associated with poor prognosis in gastrointestinal autonomic nerve tumour. Histopathology 1999;35:121–128. doi:10.1046/j.1365-2559.1999.00685.x
   PubMed Web of Science ®Google Scholar
• Fletcher CDM, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol. 2002;10(2):81–89. doi:10.1177/106689690201000201
   PubMed Web of Science ®Google Scholar
• Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006;23(2):70–83. doi:10.1053/j.semdp.2006.09.001
   PubMed Web of Science ®Google Scholar
• Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol. 2008;39(10):1411–1419. doi:10.1016/j.humpath.2008.06.025
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454(7203):436–444. doi:10.1038/nature07205
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140(6):883–899. doi:10.1016/j.cell.2010.01.025
   PubMed Web of Science ®Google Scholar
• Racz JM, Cleghorn MC, Jimenez MC, Atenafu EG, Jackson TD, Okrainec A, Venkat Raghavan L, Quereshy FA. Predictive ability of blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in gastrointestinal stromal tumors. Ann Surg Oncol. 2015;22(7):2343–2350. doi:10.1245/s10434-014-4265-6
   PubMed Web of Science ®Google Scholar
• Perez DR, Baser RE, Cavnar MJ, Balachandran VP, Antonescu CR, Tap WD, Strong VE, Brennan MF, Coit DG, Singer S, et al. Blood neutrophil-to-lymphocyte ratio is prognostic in gastrointestinal stromal tumor. Ann Surg Oncol. 2013;20(2):593–599. doi:10.1245/s10434-012-2682-y
   PubMed Web of Science ®Google Scholar
• Lindenmann J, Fink-Neuboeck N, Avian A, Pichler M, Habitzruther M, Maier A, Smolle-Juettner FM. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy. Eur J Surg Oncol. 2017;43(2):445–453. doi:10.1016/j.ejso.2016.10.015
   PubMed Web of Science ®Google Scholar
• Melling N, Grüning A, Tachezy M, Nentwich M, Reeh M, Uzunoglu FG, Vashist YK, Izbicki JR, Bogoevski D. Glasgow Prognostic Score may be a prognostic index for overall and perioperative survival in gastric cancer without perioperative treatment. Surgery 2016;159(6):1548–1556. doi:10.1016/j.surg.2016.01.018
   PubMed Web of Science ®Google Scholar
• Eren T, Burcu B, Tombalak E, Ozdemir T, Leblebici M, Ozemir IA, Ziyade S, Alimoglu O. Clinical significance of the Glasgow Prognostic Score for survival after colorectal cancer surgery. J Gastrointest Surg. 2016;20(6):1231–1238. doi:10.1007/s11605-016-3114-2
   PubMed Web of Science ®Google Scholar
• Wu M, Guo J, Guo L, Zuo Q. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Tumor Biol. 2016;37(9):12525–12533. doi:10.1007/s13277-016-5122-y
   PubMedGoogle Scholar
• Arigami T, Uenosono Y, Ishigami S, Yanagita S, Okubo K, Uchikado Y, Kita Y, Mori S, Kurahara H, Maemura K, et al. Clinical significance of the Glasgow Prognostic Score in patients with gastrointestinal stromal tumors. Anticancer Res. 2016;36(12):6687–6690. doi:10.21873/anticanres.11279
   PubMed Web of Science ®Google Scholar
• McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534–540. doi:10.1016/j.ctrv.2012.08.003
   PubMed Web of Science ®Google Scholar
• Racz JM, Brar SS, Cleghorn MC, Jimenez MC, Azin A, Atenafu EG, Jackson TD, Okrainec A, Quereshy FA. The accuracy of three predictive models in the evaluation of recurrence rates for gastrointestinal stromal tumors. J Surg Oncol. 2015;111(4):371–376. doi:10.1002/jso.23839
   PubMed Web of Science ®Google Scholar
• Suzuki S, Kajiyama H, Shimoda M, Shimazaki J, Koike N, Harada N. Prognostic factors associated with preoperative clinicophysiological outcomes of distal cholangiocarcinoma. Dig Surg. 2017;34(6):476–482. doi:10.1159/000456082
   PubMed Web of Science ®Google Scholar
• Køstner AH, Kersten C, Löwenmark T, Ydsten KA, Peltonen R, Isoniemi H, Haglund C, Gunnarsson U, Isaksson B. The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker. J Surg Oncol. 2016;114(7):895–899. doi:10.1002/jso.24415
   PubMed Web of Science ®Google Scholar
• Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 2005;8(3):265–269. doi:10.1097/01.mco.0000165004.93707.88
   PubMed Web of Science ®Google Scholar
• Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–454. doi:10.1056/NEJM199902113400607
   PubMed Web of Science ®Google Scholar
• McMillan DC, Watson WS, O'Gorman P, Preston T, Scott HR, McArdle CS. Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer 2001;39(2):210–213. doi:10.1207/S15327914nc392_8
   PubMed Web of Science ®Google Scholar
• Shimoda M, Tago K, Shiraki T, Mori S, Kato M, Aoki T, Kubota K. Risk factors for early recurrence of single lesion hepatocellular carcinoma after curative resection. World J Surg. 2016;40(10):2466–2471. doi:10.1007/s00268-016-3529-7
   PubMed Web of Science ®Google Scholar